Newsroom

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Integra LifeSciences Holdings Corporation ("Integra" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Integra LifeSciences Holdings Corporation (NASDAQ: IART) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 2, 2026 disclosure regarding Integra...

NEW YORK--(BUSINESS WIRE)--Perfect Corp. (NYSE: PERF), a global leader in augmented reality (AR) and artificial intelligence (AI) beauty and fashion tech, today announced that YouCam is one of the first platforms to integrate the newly released Kling 4.0 API. The newest AI video model from Kuaishou Technology’s Kling AI is now live across the YouCam lineup on mobile and web. Built for longer storytelling, Kling 4.0 lets users set up to 10 keyframes instead of only a first and last frame, then g...

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on FirstCash Holdings, Inc. ("FirstCash" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of FirstCash Holdings, Inc. (NASDAQ: FCFS) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 22, 2026 disclosure regarding FirstCash Holdings, Inc.Investors who...

LOS ANGELES--(BUSINESS WIRE)--AEG Presents Names Chris Hammond Senior Vice President of the Pacific Northwest...

LOS ANGELES--(BUSINESS WIRE)--Customer platform Planhat today announced it has been recognized as a Leader in the 2026 Gartner® Magic Quadrant™ for Customer Success Management Platforms for the third consecutive year. The recognition follows a period of rapid innovation for Planhat, with the recent launch of Pi, the world’s first multiplayer customer agent. Pi works alongside entire account teams, drawing on shared context to run core commercial processes from sales and renewals to implementati...

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Moderna, Inc. ("Moderna" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Moderna, Inc. (NASDAQ: MRNA) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 22, 2026 disclosure regarding Moderna, Inc.Investors who lost money on Moderna, Inc. securit...

LOS ANGELES--(BUSINESS WIRE)--Investors who lost money on Carpenter Technology Corporation ("Carpenter Technology" or the "Company") stock may have claims to recover their losses. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced a securities fraud investigation on behalf of Carpenter Technology Corporation (NYSE: CRS) investors into whether the Company may have violated the federal securities laws. The investigation follows the October 22, 2026 disclosure regarding Carpenter Tech...

中国广州--(BUSINESS WIRE)--(美国商业资讯)-- 阿联酋联邦最高委员会成员、拉斯海玛酋长谢赫·萨乌德·本·萨克尔·卡西米殿下为该酋长国首家驻华商务咨询公司揭幕，开启双方合作的新篇章。 该机构位于工业重镇广州，将作为拉斯海玛对接中国企业的重要平台，推动双方在重点领域拓展合作。 此次揭幕延续了双方数百年来的交往。早在数百年前，海上贸易便通过瓷器、珍珠等商品的往来，将拉斯海玛与中国联系起来。这段共同的历史，加上阿联酋与中国建交四十多年来积累的合作基础，为双方继续深化合作提供了有力支撑。 谢赫·萨乌德殿下表示：“历史和经验告诉我们，合作伙伴看重的不只是机遇，更是稳定、透明、良好的治理和信守承诺。这正是我们在拉斯海玛营造的环境。 “今天，拉斯海玛首家驻华商务咨询机构正式启用，标志着我们的伙伴关系迈出了重要一步。我们设立这一机构，是为了在携手前行的道路上建立一个长久的据点，让两地人民、文化和产业更加紧密地联系在一起，使合作从阶段性交往走向持续协作，从单纯的商业交易走向能够带来深刻改变的伙伴关系。” 谢赫·萨乌德殿下参观了新设立的咨询机构，并观看了中国传统舞狮及派发红包活动，为揭幕...

中國，廣州--(BUSINESS WIRE)--(美國商業資訊)-- 阿聯酋聯邦最高委員會成員、拉斯海瑪酋長謝赫·薩烏德·本·薩克爾·卡西米殿下為拉斯海瑪在中國設立的第一個商業諮詢機構舉行開幕儀式，象徵雙方的互助合作翻開了新的篇章。 這所諮詢機構坐落於廣州這座工業樞紐城市，將扮演領先平台的角色，致力維繫拉斯海瑪與中國企業之間的互動，並推動雙方在重點領域繼續合作。 這場開幕儀式建立在雙方長達數世紀的淵源之上。早在數百年前，拉斯海瑪與中國便憑因海上貿易緊密相連，雙方透過瓷器、珍珠等商品交易展開往來。這段共同的歷史，加上阿拉伯聯合大公國與中國四十多年來的外交關係，為長期合作奠定了穩固的基礎。 謝赫·薩烏德殿下表示：「歷史與經驗告訴我們，合作夥伴重視的遠不止於機會本身。他們尋找的是穩定性、透明度、治理機制以及堅定承諾。這正是我們在拉斯海瑪建立的環境。」 「今天，我們讓雙方的合作邁出了具有深遠意義的一步，設立拉斯海瑪在中國的第一家商業諮詢機構。建立這所諮詢機構讓我們在攜手前進的道路上築起了一個長久的『家』。我們在這裡連結彼此的人民、文化與產業。這麼做讓我們確保雙方的合作不再只是階段性的，而綿長不...

NEW YORK--(BUSINESS WIRE)--TG Therapeutics, Inc. (NASDAQ: TGTX), today announced initial results from the Company’s Phase 1 study evaluating azercabtagene zapreleucel (azer-cel), an investigational, allogeneic CD19-directed chimeric antigen receptor (CAR) T-cell therapy, in patients with progressive multiple sclerosis (MS). The data represent the first reported clinical evaluation of an allogeneic CD19-directed CAR T-cell therapy in progressive MS and were presented in a late-breaking oral sess...